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July 1, 2008:82–4With all of these limitations, does this mean that developing
ountries should forget about medical research? No, but they
hould have realistic expectations and rational policies that can
uide the utilization of their very limited resources. These policies
hould probably focus research funding on selective centers with
elected high-quality investigators who can use these resources to
roduce high-quality research. It is also very important to encour-
ge collaboration with investigators and institutions in developed
ountries. We have recently analyzed the research productivity of
he medical faculty in our institution (2) and found that collabo-
ation with investigators in developed countries significantly im-
roved the quality of our medical center’s research output.
Cardiovascular research is essential for the advancement of
uman health. The study by Prabhakaran et al. (1) indicates that
eveloping countries have not yet made significant contributions in
his field, in spite of the fact that their populations carry a major
ercentage of the global burden of cardiovascular diseases. The
roblem is clear. The solutions, however, are very difficult.
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eply
e thank Dr. Dakik for his interest in and comments on our
rticle (1). We largely agree with his observations about the
ultifactorial determinants of the low research output related to
ardiovascular disease (CVD) research in low-income and low-
iddle-income countries. We do, however, differ with some
erspectives. For example, Dr. Dakik argues that collaboration
ith investigators in developed countries raises the quality of
ublished articles. Although this is true to some extent, it hampers
ocal capacity enhancement and original research from developing-
ountry scientists, as in most such publications, the corresponding
uthors are from the developed country (data not shown). Further,here are hardly any collaborative studies aimed at improving
ealth systems, quality of care, and translational research. Collab-
ration with developed-country investigators, in the absence of
ational funding, compels developing-country investigators to
ccept research agendas set by their funding partners. Availability
f national funding for research enables a greater balance to be
ttained in research undertaken by developing-country investiga-
ors. The aim of our article was to raise awareness of the low
riority afforded to CVD and to argue for enhanced allocation of
esources to CVD prevention and control.
In addition, there is a lack of information on how the estimated
2.4 billion spent by low- and middle-income countries in health
esearch and development in 2003 (2) was allocated across different
isease or disciplinary categories. Although anecdotal information
rom these countries suggests that public-sector spending on CVD-
elated research is limited, this question needs further systematic
uantification.
Although we need to further study the issues raised by Dr.
akik, as well as other determinants of the volume and variety of
VD-related research, we cannot ignore the advancing epidemic
f CVD in developing countries. Therefore, governments need to
pend at least a small portion of their funds on translational and
perational research for enhancing the provision of inexpensive,
ffective, and evidence-based care for established CVD and to
evelop cost-effective strategies aimed at health promotion for
rimary prevention of CVD.
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